HomeCompareNNOMF vs JNJ

NNOMF vs JNJ: Dividend Comparison 2026

NNOMF yields 332.23% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNOMF wins by $3041.09M in total portfolio value
10 years
NNOMF
NNOMF
● Live price
332.23%
Share price
$0.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3041.11M
Annual income
$1,910,109,458.01
Full NNOMF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NNOMF vs JNJ

📍 NNOMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNNOMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NNOMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NNOMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NNOMF
Annual income on $10K today (after 15% tax)
$28,239.20/yr
After 10yr DRIP, annual income (after tax)
$1,623,593,039.31/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NNOMF beats the other by $1,623,592,335.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NNOMF + JNJ for your $10,000?

NNOMF: 50%JNJ: 50%
100% JNJ50/50100% NNOMF
Portfolio after 10yr
$1520.56M
Annual income
$955,055,142.90/yr
Blended yield
62.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NNOMF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-1.5
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NNOMF buys
0
JNJ buys
0
No recent congressional trades found for NNOMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNNOMFJNJ
Forward yield332.23%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$3041.11M$20.0K
Annual income after 10y$1,910,109,458.01$827.78
Total dividends collected$2931.28M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: NNOMF vs JNJ ($10,000, DRIP)

YearNNOMF PortfolioNNOMF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$43,923$33,222.59$10,676$355.77+$33.2KNNOMF
2$183,373$136,375.92$11,407$389.39+$172.0KNNOMF
3$728,319$532,110.16$12,198$426.53+$716.1KNNOMF
4$2,754,470$1,975,167.94$13,056$467.62+$2.74MNNOMF
5$9,928,584$6,981,301.38$13,987$513.12+$9.91MNNOMF
6$34,141,668$23,518,083.44$14,998$563.56+$34.13MNNOMF
7$112,113,097$75,581,512.08$16,098$619.52+$112.10MNNOMF
8$351,915,839$231,954,824.82$17,295$681.69+$351.90MNNOMF
9$1,057,009,157$680,459,209.86$18,599$750.82+$1056.99MNNOMF
10$3,041,109,256$1,910,109,458.01$20,022$827.78+$3041.09MNNOMF

NNOMF vs JNJ: Complete Analysis 2026

NNOMFStock

Nano One Materials Corp. produces cathode active materials for lithium-ion battery applications in electric vehicles, energy storage systems, and consumer electronics applications. It serves the original equipment and cathode manufacturers. The company was incorporated in 1987 and is headquartered in Burnaby, Canada.

Full NNOMF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NNOMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NNOMF vs SCHDNNOMF vs JEPINNOMF vs ONNOMF vs KONNOMF vs MAINNNOMF vs ABBVNNOMF vs MRKNNOMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.